Eltoprazine

DB12883InvestigationalSmall molecule

Eltoprazine has been used in trials studying the treatment of Schizophrenia and Cognitive Impairment.

Chemical structure of Eltoprazine
Formula / weight
C12H16N2O2 · 220.272 g/mol (avg)

Resolves to

Compound
UNII510M006KO6CAS98224-03-4ChEMBLCHEMBL282614PubChem65853
Structure
InChIKeyWVLHGCRWEHCIOT-UHFFFAOYSA-NSMILESC1CN(CCN1)C1=C2OCCOC2=CC=C1
Targets
P28222HTR1BP28335HTR2CP08908HTR1A

What you can answer from here — as of August 30, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
707Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Eltoprazine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In